Effect of Vibration and Non-Vibration Foam Rolling

NCT07414238 | Completed

• 1 other identifier: CBU-FTR-ES-O8
• Study Type: interventional
• Target: 14
• Locations: 1 country
• Sites: 1

Brief Summary

This study aims to compare the immediate effects of vibration and non-vibration foam rolling on the biomechanical and viscoelastic properties of knee flexor and extensor muscles in young male recreational athletes. Fourteen athletes will be included in this study, planned as a randomized controlled cross-over study. All athletes will complete three interventions: 1) vibration foam rolling (VFR), 2) non-vibration foam rolling (FR), and 3) rest control. Pre- and post-test assessment will include the biomechanical and viscoelastic properties of knee flexor and extensor muscles, assessed with the MyotonPro.

Conditions

Self-Myofascial Release

Keywords

Athletes; Biceps femoris; Myofascial release; Rectus femoris

Outcome Measures

Primary Outcomes (3)

• Muscle tone

  The muscle tone (Hz), as a biomechanical property of the knee flexors and extensors, will be assessed using the MyotonPro (Myoton AS, Tallinn, Estonia). The rectus femoris will be preferred as the primary extensor and the biceps femoris as the principal flexor for the assessment, due to their anatomical and functional centrality. To ensure accuracy, the probe will be applied perpendicularly in three successive increments, with automatic alerts for any deviation. The rectus femoris measurement will be taken at the midpoint between the anterior superior iliac spine and the medial patellar border, with the subject supine and a 20 cm roller under the knees. For the biceps femoris, the subject will be prone with an ankle pillow for relaxation, with measurements taken at the midpoint of the long head's longitudinal axis to ensure consistency. Each muscle will be measured twice in immediate succession, using the mean for analysis.

  one week

• Stiffness

  The stiffness (N/m), as a biomechanical property of the knee flexors and extensors, will be assessed using the MyotonPro (Myoton AS, Tallinn, Estonia). The rectus femoris will be preferred as the primary extensor and the biceps femoris as the principal flexor for the assessment, due to their anatomical and functional centrality. To ensure accuracy, the probe will be applied perpendicularly in three successive increments, with automatic alerts for any deviation. The rectus femoris measurement will be taken at the midpoint between the anterior superior iliac spine and the medial patellar border, with the subject supine and a 20 cm roller under the knees. For the biceps femoris, the subject will be prone with an ankle pillow for relaxation, with measurements taken at the midpoint of the long head's longitudinal axis to ensure consistency. Each muscle will be measured twice in immediate succession, using the mean for analysis.

  one week

• Elasticity

  The elasticity (unitless), as a biomechanical property of the knee flexors and extensors, will be assessed using the MyotonPro (Myoton AS, Tallinn, Estonia). The rectus femoris will be preferred as the primary extensor and the biceps femoris as the principal flexor for the assessment, due to their anatomical and functional centrality. To ensure accuracy, the probe will be applied perpendicularly in three successive increments, with automatic alerts for any deviation. The rectus femoris measurement will be taken at the midpoint between the anterior superior iliac spine and the medial patellar border, with the subject supine and a 20 cm roller under the knees. For the biceps femoris, the subject will be prone with an ankle pillow for relaxation, with measurements taken at the midpoint of the long head's longitudinal axis to ensure consistency. Each muscle will be measured twice in immediate succession, using the mean for analysis.

  one week

Secondary Outcomes (2)

• The mechanical stress relaxation time

  one week

• The ratio of relaxation and deformation time

  one week

Study Arms (3)

VFR Group

ACTIVE COMPARATOR

Athletes will be performed three sets of VFR for 30 s, with a 30 s break between each set and exercise. The rolling frequency will be standardized using a metronome set at 60 beats per minute. Athletes will be instructed to roll at a velocity of two metronome beats for each rolling direction. Intensity of pressure will be controlled with a target rating of 7 of 10 on a Numerical Rating Scale (0 = no discomfort and 10 = maximum discomfort) during VFR intervention. The target muscle groups will be the anterior and posterior thigh. During VFR, the vibrator booster will be set to a frequency of 48 hz, which is within the optimal frequency range (12 to 90 hz) to influence the musculoskeletal system, and an amplitude of 1.95 mm.

Other: VFR

FR Group

ACTIVE COMPARATOR

Athletes will be performed three sets of FR for 30 s, with a 30 s break between each set and exercise. The rolling frequency will be standardized using a metronome set at 60 beats per minute. Athletes will be instructed to roll at a velocity of two metronome beats for each rolling direction. Intensity of pressure will be controlled with a target rating of 7 of 10 on a Numerical Rating Scale (0 = no discomfort and 10 = maximum discomfort) during FR intervention. The target muscle groups will be the anterior and posterior thigh. The FR will be conducted using the same vibration foam rolling device, but with the vibration mode deactivated. This ensures that the physical dimensions and material properties of the roller remain constant across conditions, with the only variable being the presence or absence of mechanical vibration.

Other: FR

Control Group

NO INTERVENTION

No intervention will be applied to the control group.

Interventions

VFR OTHER

Athletes will be performed three sets of VFR for 30 s, with a 30 s break between each set and exercise. The rolling frequency will be standardized using a metronome set at 60 beats per minute. Athletes will be instructed to roll at a velocity of two metronome beats for each rolling direction. Intensity of pressure will be controlled with a target rating of 7 of 10 on a Numerical Rating Scale (0 = no discomfort and 10 = maximum discomfort) during VFR intervention. The target muscle groups will be the anterior and posterior thigh. During VFR, the vibrator booster will be set to a frequency of 48 hz, which is within the optimal frequency range (12 to 90 hz) to influence the musculoskeletal system, and an amplitude of 1.95 mm.

VFR Group

FR OTHER

Athletes will be performed three sets of FR for 30 s, with a 30 s break between each set and exercise. The rolling frequency will be standardized using a metronome set at 60 beats per minute. Athletes will be instructed to roll at a velocity of two metronome beats for each rolling direction. Intensity of pressure will be controlled with a target rating of 7 of 10 on a Numerical Rating Scale (0 = no discomfort and 10 = maximum discomfort) during FR intervention. The target muscle groups will be the anterior and posterior thigh. The FR will be conducted using the same vibration foam rolling device, but with the vibration mode deactivated. This ensures that the physical dimensions and material properties of the roller remain constant across conditions, with the only variable being the presence or absence of mechanical vibration.

FR Group

Eligibility Criteria

• Age: 18 Years - 22 Years
• Sex: male
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• To volunteer to participate in the study
• To engage in sports activities at least 2-3 days a week

You may not qualify if:

• Players with a history of major sports injury or time-loss injury that required surgery
• Musculoskeletal problems that compromised their performance in the study
• A history of lower extremity pathology in the 3 months before the study

Sponsors & Collaborators

• Celal Bayar University: lead

Study Sites (1)

Manisa Celal Bayar University

Manisa, Turkey (Türkiye)

Location

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Masking Details: Outcome measures assessments will be performed by an investigator who is blinded to group allocation
• Purpose: TREATMENT
• Intervention Model: CROSSOVER
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Model Details: Randomized controlled cross-over study

Study Record Dates

• First Submitted: February 4, 2026
• First Posted: February 17, 2026
• Study Start: February 10, 2026
• Primary Completion: February 25, 2026
• Study Completion: February 25, 2026
• Last Updated: March 13, 2026

Record last verified: 2026-03

Locations

TU (1)